Time in range-A1c hemoglobin relationship in continuous glucose monitoring of type 1 diabetes: A real-world study

24Citations
Citations of this article
54Readers
Mendeley users who have this article in their library.

Abstract

Introduction The availability of easily accessible continuous glucose monitoring (CGM) metrics can improve glycemic control in diabetes, and they may even become a viable alternative to hemoglobin A1c (HbA1c) laboratory tests in the next years. The REALISM-T1D study (REAl-Life glucoSe Monitoring in Type 1 Diabetes) was aimed at contributing, with real-world data, to a deeper understanding of these metrics, including the time in range (TIR)-HbA1c relationship, to facilitate their adoption by diabetologists in everyday practice. Research design and methods 70 adults affected by type 1 diabetes were monitored for 1 year by means of either flash (FGM) or real-time (rtCGM) glucose monitoring devices. Follow-up visits were performed after 90, 180 and 365 days from baseline and percentage TIR 70-180 evaluated for the 90-day time period preceding each visit. HbA1c tests were also carried out in the same occasions and measured values paired with the corresponding TIR data. Results A monovariate linear regression analysis confirms a strong correlation between TIR and HbA1c as found in previous studies, but leveraging more homogeneous data (n=146) collected in real-life conditions. Differences were determined between FGM and rtCGM devices in Pearson's correlation (r FGM =0.703, r rtCGM =0.739), slope (β 1,FGM =-11.77, β 1,rtCGM =-10.74) and intercept (β 0,FGM =141.19, β 0,rtCGM =140.77) coefficients. Normality of residuals and homoscedasticity were successfully verified in both cases. Conclusions Regression lines for two patient groups monitored through FGM and rtCGM devices, respectively, while confirming a linear relationship between TIR and A1c hemoglobin (A1C) in good accordance with previous studies, also show a statistically significant difference in the regression intercept, thus suggesting the need for different models tailored to device characteristics. The predictive power of A1C as a TIR estimator also deserves further investigations.

Cite

CITATION STYLE

APA

Valenzano, M., Cibrario Bertolotti, I., Valenzano, A., & Grassi, G. (2021). Time in range-A1c hemoglobin relationship in continuous glucose monitoring of type 1 diabetes: A real-world study. BMJ Open Diabetes Research and Care, 9(1). https://doi.org/10.1136/bmjdrc-2019-001045

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free